Jay Jeffrey R as of June 30, 2013
Portfolio Holdings for Jay Jeffrey R
Jay Jeffrey R holds 32 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Hyperion Therapeutics | 16.8 | $21M | 964k | 22.00 | |
| Furiex Pharmaceuticals | 13.3 | $17M | 494k | 34.07 | |
| D Stemline Therapeutics | 11.2 | $14M | 596k | 23.84 | |
| Biodel | 6.1 | $7.7M | 1.9M | 4.18 | |
| Ambit Bioscience | 5.5 | $7.0M | 1.0M | 7.00 | |
| Geron Corporation (GERN) | 4.4 | $5.6M | 3.8M | 1.50 | |
| Pain Therapeutics | 4.1 | $5.1M | 2.3M | 2.21 | |
| Sunshine Heart | 4.0 | $5.1M | 950k | 5.37 | |
| Durata Therapeutics | 3.6 | $4.6M | 639k | 7.20 | |
| Nordion | 3.1 | $4.0M | 538k | 7.40 | |
| D Horizon Pharma | 3.1 | $3.9M | 1.6M | 2.46 | |
| OncoGenex Pharmaceuticals | 2.7 | $3.4M | 347k | 9.80 | |
| Impax Laboratories | 2.4 | $3.0M | 150k | 19.94 | |
| Trinity Biotech | 2.2 | $2.7M | 163k | 16.85 | |
| RTI Biologics | 2.0 | $2.5M | 674k | 3.76 | |
| Dyax | 2.0 | $2.5M | 728k | 3.46 | |
| Mast Therapeutics | 2.0 | $2.5M | 5.8M | 0.43 | |
| Protalix BioTherapeutics | 1.6 | $2.0M | 399k | 4.91 | |
| Myriad Genetics (MYGN) | 1.5 | $1.9M | 70k | 26.87 | |
| Volcano Corporation | 1.4 | $1.8M | 100k | 18.13 | |
| Targacept | 1.2 | $1.6M | 368k | 4.27 | |
| AVANIR Pharmaceuticals | 0.9 | $1.2M | 259k | 4.60 | |
| XenoPort | 0.9 | $1.2M | 233k | 4.95 | |
| Mei Pharma | 0.9 | $1.1M | 158k | 7.13 | |
| Pernix Therapeutics Holdings | 0.8 | $1.1M | 297k | 3.61 | |
| Palatin Technologies | 0.8 | $1.1M | 1.7M | 0.62 | |
| Vascular Solutions | 0.5 | $680k | 46k | 14.72 | |
| Wright Med Group Inc right 03/01/2019 | 0.4 | $542k | 200k | 2.71 | |
| Celsion Corporation | 0.1 | $190k | 186k | 1.02 | |
| CryoLife (AORT) | 0.1 | $164k | 26k | 6.25 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $102k | 12k | 8.78 | |
| AMAG Pharmaceuticals | 0.0 | $3.0k | 150.00 | 20.00 |
